You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Borderline resectable

Showing 1 - 25 of 1,650
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in Aurora (TTI-101)

Not yet recruiting
  • Pancreatic Cancer
  • Aurora, Colorado
    University of Colorado
Nov 30, 2023

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)

Not yet recruiting
  • Borderline Resectable Carcinoma
  • Biliary Tract Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Borderline Resectable Pancreatic Cancer Trial in Verona (Intraoperative radiotherapy)

Suspended
  • Borderline Resectable Pancreatic Cancer
  • Intraoperative radiotherapy
  • Verona, Italy
    General and Pancreatic Surgery Unit, Pancreas Institute, Univers
Nov 1, 2022

NSCLC Trial (Durvalumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Jun 22, 2023

ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

Recruiting
  • Pancreatic Cancer
  • SIGNATERA™ ctDNA testing
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Oct 26, 2022

Pancreatic Cancer Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

Recruiting
  • Pancreatic Cancer
  • Daily Adaptive External Beam Radiation Therapy
  • Saint Louis, Missouri
    Washington University, St. Louis
Mar 7, 2023

Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,

Not yet recruiting
  • Pancreatic Cancer, Stage IB
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jan 4, 2023

Pancreatic Cancer, Locally Advanced Trial in Beijing (Later-line therapy)

Recruiting
  • Pancreatic Cancer
  • Locally Advanced
  • Later-line therapy
  • Beijing, China
    Department of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023

Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dose-Painted Intensity Modulated Radiotherapy
  • Dublin, Ireland
    St Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023

Predictive Factors for Resection and Survival in Type A

Not yet recruiting
  • Carcinoma, Pancreatic Ductal
  • Resection
  • No Resection
  • (no location specified)
Aug 3, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +3 more
  • Hafnium Oxide-containing Nanoparticles NBTXR3
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Pancreatic Cancer Trial in Baltimore (Cyclophosphamide, GVAX, Pembrolizumab)

Active, not recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jan 5, 2023

Locally Advanced Pancreatic Cancer (LAPC) Trial in Herlev (Gemcitabine, Nab-paclitaxel, Nivolumab)

Recruiting
  • Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Oct 13, 2022

Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)

Active, not recruiting
Has Results
  • Pancreatic Ductal Adenocarcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 8, 2022

Pancreatic Cancer Trial in Tianjin (surufatinib + gemcitabine + nab-paclitaxel)

Recruiting
  • Pancreatic Cancer
  • surufatinib + gemcitabine + nab-paclitaxel
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jun 15, 2023

Surgery After Neoadjuvant Chemotherapy in Locally Advanced

Completed
  • Postoperative Complications
  • surgery after neoadjuvant chemotherapy
  • Seoul, Korea, Republic of
    Asan medical center
Jun 1, 2023

Locally Advanced Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Unresectable Skin Squamous Cell

Recruiting
  • Locally Advanced Skin Squamous Cell Carcinoma
  • +2 more
  • Atezolizumab
  • Stereotactic Body Radiation Therapy
  • Duarte, California
    City of Hope Medical Center
Aug 2, 2022

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Hong Kong (Nivolumab, Hepatectomy)

Completed
  • Hepatocellular Carcinoma
  • +2 more
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Jul 20, 2022

Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic

Recruiting
  • Untreated Resectable Pancreatic Adenocarcinoma
  • +2 more
  • Paclitaxel protein bound
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
May 10, 2022

Pancreatic Cancer Trial in Shanghai (Neoadjuvant gemcitabine plus nab-paclitaxel, Neoadjuvant gemcitabine plus nab-paclitaxel

Recruiting
  • Pancreatic Cancer
  • Neoadjuvant gemcitabine plus nab-paclitaxel
  • +2 more
  • Shanghai, Shanghai, China
    Changhai Hospital
Mar 8, 2022

Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • Nab-paclitaxel and gemcitabine for R-PDAC Patients
  • Nab-paclitaxel and gemcitabine for BR-PDAC Patients
  • Scottsdale, Arizona
  • +3 more
Mar 8, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

Not yet recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Biospecimen Collection
  • +9 more
  • Los Angeles, California
    Yonemoto,Lisa
Jan 13, 2023